Zacks released a batch of research reports today covering several large and micro-cap stocks. Johnson & Johnson beat Q4 earnings and sales estimates. Their medicine unit is growing thanks to drugs like Darzalex, but they are dealing with the Stelara patent expiration and ongoing legal issues. Netflix posted solid Q4 numbers with revenue up 18% to $12.05 billion and memberships hitting 325 million. Ad revenue is growing fast, but there are still concerns around regulatory hurdles for the Warner Bros. Discovery acquisition and high debt levels. Arista Networks is seeing strong demand for cloud networking and AI data centers. While inventory management has improved, rising costs and competition are putting pressure on margins. On the smaller side, Omega Flex is struggling with a slowdown in residential construction, while AXIL Brands is performing well as they expand retail distribution. Other notes include upgrades for GE Aerospace and PNC, while Pfizer and Qualcomm were downgraded due to weak guidance and margin issues respectively.